GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APP, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FDPS, FUT7, HSD17B1, HSD17B2, HSD17B3, MET, PPARA, PTGES |
8.47236 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, APP, CA1, CA12, CA2, CA4, CA6, CA7, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FDPS, FUT7, GLO1, HSD17B3, PIM1, PPARA, PTGES, TYR, XDH |
8.21529 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7 |
6.9823 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, APEX1, AR, AURKB, AXL, CSNK2A1, CYP1B1, F3, FLT3, GLO1, IGF1R, KDR, MAP2K1, MCL1, MET, PIM1, PPARA, PTPN1, RELA, SRC, TOP2A, XDH |
6.9823 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, APEX1, AR, AURKB, AXL, CSNK2A1, CYP1B1, F3, FLT3, GLO1, IGF1R, KDR, MAP2K1, MCL1, MET, PIM1, PTPN1, RELA, SRC, TOP2A, XDH |
6.79694 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FDPS, HSD17B1, HSD17B2, HSD17B3 |
6.6729 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APEX1, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA6, CA7, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, F3, FABP3, FABP4, FDPS, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSD17B3, IGF1R, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP12, PIM1, PPARA, PTGES, PTPN1, PTPRS, RELA, RORC, SRC, TOP2A, TYR, XDH |
6.62566 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, APP, AR, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F3, FLT3, KDR, MAP2K1, MAP3K7, MCL1, MET, MMP12, PTPN1, RELA, SRC, XDH |
6.27847 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, APP, AR, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F3, FLT3, KDR, MAP2K1, MAP3K7, MCL1, MET, MMP12, PTPN1, RELA, SRC, XDH |
6.27326 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AR, AXL, CA2, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, FLT3, HSD17B2, HSD17B3, KDR, MAP2K1, PPARA, PTPRS, RELA, SRC, TYR |
6.24615 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, APEX1, AR, AURKB, AXL, CSNK2A1, CYP1B1, F3, FLT3, GLO1, IGF1R, KDR, MAP2K1, MCL1, PIM1, PTPN1, RELA, SRC, TOP2A, XDH |
6.23062 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APEX1, APP, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, KDR, PTGES, RELA, SRC |
6.19687 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA6, CA7 |
6.02657 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, APEX1, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA6, CA7, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FDPS, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSD17B3, IGF1R, KDR, MAOA, MAP2K1, MAP3K7, MET, PIM1, PPARA, PTGES, PTPN1, PTPRS, RELA, RORC, SRC, TOP2A, TYR, XDH |
5.95394 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, APP, AR, AXL, CYP1B1, F3, FLT3, KDR, MAP2K1, MAP3K7, MCL1, MET, PTPN1, RELA, SRC, XDH |
5.8829 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, APEX1, APP, AR, AXL, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FLT3, HSD17B2, IGF1R, KDR, MCL1, PPARA, PTGES, RELA, RORC, SRC, TYR |
5.70242 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, APEX1, APP, AR, AURKB, AXL, CA2, CACNA1C, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP4, FLT3, FUT7, GLO1, HSD17B2, HSD17B3, KDR, MAP2K1, MCL1, MET, PIM1, PPARA, PTPRS, RELA, RORC, SRC, TOP2A, TYR |
5.63241 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, AKR1B1, APEX1, APP, AR, AURKB, AXL, CA12, CA2, CA7, CACNA1C, CYP19A1, CYP1A1, CYP1B1, F3, FABP3, FABP4, FLT3, HSD17B1, HSD17B2, HSD17B3, KDR, MAOA, MCL1, MET, PPARA, SRC, XDH |
5.44029 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, GLO1, IGF1R, KDR, MCL1, MET, PIM1, PPARA, PTPN1, RELA, SRC |
5.24349 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, TYR |
5.24349 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, APEX1, APP, AR, AXL, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FABP3, HSD17B2, IGF1R, PPARA, PTGES, RELA, RORC, SRC, TYR |
5.09422 |
[BP] GO:0033993 |
response to lipid
|
AR, AXL, CA2, CSNK2A1, CYP1A1, CYP1A2, FABP3, FLT3, HSD17B2, PTGES, RELA, RORC, SRC, TYR |
5.04556 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, APP, AR, CDC25B, CSNK2A1, CYP1B1, F3, FABP3, FLT3, IGF1R, KDR, MAP2K1, MMP12, PIM1, PTGES, RELA, SRC, XDH |
5.03578 |
[BP] GO:0014070 |
response to organic cyclic compound
|
APEX1, APP, AR, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FLT3, PTGES, RELA, RORC, SRC, TYR |
5.03578 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, GLO1, IGF1R, KDR, MCL1, MET, PIM1, PTPN1, RELA, SRC |
4.96251 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, APP, AR, AXL, CSNK2A1, CYP1B1, F3, FLT3, KDR, MAP2K1, MAP3K7, MCL1, MET, MMP12, PTPN1, RELA, SRC, XDH |
4.827 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, APEX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD17B1, HSD17B2, HSD17B3, MAOA, TYR, XDH |
4.81182 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD17B1, HSD17B2, HSD17B3 |
4.80374 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD17B1, HSD17B2, HSD17B3 |
4.4641 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FDPS, FUT7, MET, PPARA, PTGES |
4.42361 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, APP, AR, AURKB, AXL, CSNK2A1, CYP1B1, F3, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MCL1, MET, PTPN1, RELA, SRC, XDH |
4.35754 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, GLO1, IGF1R, KDR, MCL1, PIM1, PTPN1, RELA, SRC |
4.24239 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, APP, AR, AURKB, AXL, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, F3, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MCL1, MET, MMP12, PTPN1, PTPRS, RELA, SRC, XDH |
4.18269 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, APEX1, APP, AR, AXL, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FLT3, HSD17B2, IGF1R, KDR, MCL1, PPARA, PTGES, RELA, RORC, SRC, TYR |
4.18269 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, APP, AR, AURKB, AXL, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, F3, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MCL1, MET, MMP12, PTPN1, PTPRS, RELA, SRC, XDH |
4.09904 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, APP, AR, AXL, CA2, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FLT3, HSD17B2, HSD17B3, KDR, MAP2K1, MCL1, PIM1, PPARA, PTPRS, RELA, RORC, SRC, TYR |
4.01311 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, APEX1, APP, AR, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, F3, FABP3, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MCL1, MET, MMP12, PIM1, PPARA, PTPN1, RELA, RORC, SRC, TOP2A, XDH |
3.98283 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, APP, AR, AURKB, AXL, CA2, CA6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, F3, FABP3, FABP4, FLT3, HSD17B2, IGF1R, KDR, MAP2K1, MAP3K7, MCL1, MMP12, PPARA, PTGES, PTPN1, RELA, RORC, SRC, TOP2A, TYR |
3.94236 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1B1, FDPS, HSD17B3, MAOA, TYR |
3.91013 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, FABP3, FABP4, GLO1, IGF1R, KDR, MAP2K1, MCL1, MET, MMP12, PIM1, PPARA, PTGES, PTPN1, PTPRS, RELA, RORC, SRC, TOP2A, XDH |
3.83348 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGES |
3.80035 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, APP, CYP19A1, F3, FABP4, IGF1R, MAP2K1, MAP3K7, MCL1, MET, MMP12, PPARA, PTPN1, PTPRS, RELA, SRC, XDH |
3.69302 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CBR1, CYP1A1, CYP1A2, CYP1B1, PTGES |
3.69302 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGES |
3.65427 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.59307 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1, RELA, SRC |
3.58086 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, RELA, SRC |
3.58086 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
AR, MAP3K7, PIM1, PPARA, RELA, RORC, SRC |
3.57491 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1, RELA |
3.50565 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD17B1, HSD17B2, HSD17B3 |
3.50565 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, AKR1B1, APEX1, APP, AR, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, F3, FABP3, FABP4, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MCL1, MET, MMP12, PIM1, PPARA, PTPN1, RELA, RORC, SRC, TOP2A, XDH |
3.4833 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MAP2K1, MET, SRC |
3.45971 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APEX1, APP, AR, AURKB, AXL, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, F3, FABP3, FABP4, FDPS, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSD17B3, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP12, PIM1, PPARA, PTGES, PTPN1, PTPRS, RELA, RORC, SRC, TOP2A, TYR, XDH |
3.45625 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APEX1, APP, AR, AURKB, AXL, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, F3, FABP3, FABP4, FDPS, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSD17B3, IGF1R, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP12, PIM1, PPARA, PTGES, PTPN1, PTPRS, RELA, RORC, SRC, TOP2A, TYR, XDH |
3.4322 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MAP2K1, MET, SRC |
3.4322 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1B1, KDR, RELA |
3.41839 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, APEX1, APP, AURKB, AXL, CDC25B, CSNK2A1, FDPS, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, PTPN1, PTPRS, SRC, XDH |
3.40983 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, APP, AR, AXL, CSNK2A1, CYP1B1, F3, FABP4, FLT3, KDR, MAP2K1, MAP3K7, MCL1, MET, MMP12, PTPN1, RELA, SRC, XDH |
3.38208 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, SRC |
3.36236 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, GLO1, HSD17B3 |
3.33048 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, APEX1, APP, AR, AURKB, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MCL1, PTPN1, RELA, RORC, SRC, TOP2A |
3.33048 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, FDPS, HSD17B1, HSD17B2, HSD17B3 |
3.33048 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, APEX1, APP, AR, AXL, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, F3, IGF1R, KDR, MAP2K1, MET, MMP12, PPARA, PTPN1, SRC |
3.33048 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CACNA1C, CYP19A1, CYP1A1, CYP1B1, HSD17B1, HSD17B2, HSD17B3 |
3.32185 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, APP, AR, FLT3, KDR, MAP2K1, MAP3K7, PTPN1, SRC, XDH |
3.31191 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA, PTGES |
3.26389 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, CDC25B, CSNK2A1, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC |
3.26375 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, APEX1, AR, CA2, CSNK2A1, CYP1A2, FABP3, FLT3, PPARA, RELA, SRC |
3.19804 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, APEX1, APP, AURKB, AXL, CDC25B, CSNK2A1, FDPS, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, PTPN1, PTPRS, SRC, XDH |
3.18039 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.17034 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, FABP3, PPARA |
3.14784 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, APEX1, APP, AR, CA2, CSNK2A1, CYP1A2, FABP3, FLT3, IGF1R, PPARA, RELA, SRC |
3.07422 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CSNK2A1, CYP19A1, CYP1A1, FDPS, HSD17B1, HSD17B2, HSD17B3, PTGES |
3.06536 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, FABP3, FABP4, GLO1, IGF1R, KDR, MAP2K1, MCL1, MET, MMP12, PIM1, PPARA, PTGES, PTPN1, PTPRS, RELA, RORC, SRC, TOP2A, XDH |
3.0268 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, APEX1, APP, AXL, CA12, CA2, CA7, CACNA1C, FABP3, FABP4, FLT3, MCL1, MET, SRC |
2.94039 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGES |
2.90748 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, APP, AR, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, PTPN1, SRC, XDH |
2.90748 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.85996 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APEX1, APP, FABP3, IGF1R, PPARA, RELA, SRC |
2.83443 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, APEX1, APP, AR, AXL, CYP1A1, CYP1B1, FABP4, FLT3, IGF1R, KDR, RELA, RORC, SRC |
2.83375 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
APEX1, APP, AR, CYP1A1, CYP1B1, FLT3, RORC, SRC |
2.82458 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APEX1, APP, CACNA1C, CYP19A1, CYP1B1, F3, IGF1R, KDR, MET, SRC |
2.79947 |
[BP] GO:0032787 |
None
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, GLO1, PPARA, PTGES |
2.75642 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CYP1A1, FABP3, FDPS, FLT3, PPARA, RORC, SRC |
2.73823 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CBR1, CYP1A1, CYP1A2, CYP1B1, PTGES |
2.69656 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, RELA, SRC |
2.67927 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APEX1, APP, CYP19A1, CYP1B1, F3, IGF1R, KDR, MET, SRC |
2.66592 |
[BP] GO:0048608 |
reproductive structure development
|
AR, AXL, CYP19A1, HSD17B2, HSD17B3, MAP2K1, SRC |
2.64001 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 |
2.64001 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, AKR1B10, ALOX5, APP, AR, AXL, CACNA1C, CYP19A1, CYP1A2, CYP1B1, F3, FABP4, HSD17B2, IGF1R, MCL1, MET, MMP12, PIM1, PPARA, RELA, RORC, SRC, TYR |
2.64001 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, F3, FABP4, KDR, MAP2K1, MET, MMP12, PPARA, PTPRS, RELA |
2.62702 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, FDPS |
2.58747 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, APEX1, APP, AR, AXL, CYP1A1, CYP1A2, CYP1B1, FABP4, FLT3, IGF1R, KDR, RELA, RORC, SRC |
2.58305 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AR, AURKB, CYP1A1, FLT3, MAP2K1, MET, PIM1, SRC, TYR |
2.54604 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, APEX1, AXL, CYP1B1, KDR, RELA, SRC |
2.54469 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1A1, CYP1B1, KDR, RELA, SRC |
2.47656 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, CDC25B, CSNK2A1, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC |
2.46864 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, APEX1, AXL, CYP1B1, RELA, SRC |
2.46479 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APEX1, APP, CYP19A1, CYP1B1, F3, IGF1R, KDR, MET, SRC |
2.46094 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, AKR1B1, APP, AR, AURKB, AXL, CSNK2A1, CYP1B1, F3, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MCL1, MET, MMP12, PTPN1, PTPRS, RELA, SRC, XDH |
2.40784 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, FABP3, PPARA |
2.39284 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.39284 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.32055 |
[BP] GO:1901653 |
cellular response to peptide
|
AKR1B1, APEX1, APP, IGF1R, RELA, SRC |
2.32055 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, CA2, CA7, CACNA1C, KDR, SRC |
2.32055 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, GLO1, PIM1, PPARA, PTGES, TYR |
2.32029 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, FDPS |
2.32029 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, APP, AR, AURKB, AXL, CDC25B, CSNK2A1, CYP1A1, CYP1A2, F3, FLT3, FUT7, GLO1, IGF1R, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP12, PIM1, PPARA, PTPN1, PTPRS, RELA, SRC, TOP2A, TYR, XDH |
2.32029 |
[BP] GO:0032872 |
regulation of stress-activated MAPK cascade
|
APP, IGF1R, MAP2K1, MAP3K7, PTPN1, XDH |
2.25558 |
[BP] GO:0070302 |
regulation of stress-activated protein kinase signaling cascade
|
APP, IGF1R, MAP2K1, MAP3K7, PTPN1, XDH |
2.25114 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, APP, AR, AURKB, CDC25B, CSNK2A1, F3, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP12, PPARA, PTPN1, RELA, RORC, SRC, TOP2A, XDH |
2.25114 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, SRC, TOP2A |
2.25114 |
[BP] GO:0006081 |
None
|
AKR1B10, CYP1B1, GLO1, RELA |
2.25114 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, FABP3, HSD17B2, KDR, PTGES, RELA, SRC |
2.24302 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.2387 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, AR, CDC25B, CSNK2A1, F3, FLT3, IGF1R, KDR, MMP12, PIM1, RELA |
2.23107 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APEX1, APP, CYP19A1, CYP1B1, F3, IGF1R, KDR, MET, SRC |
2.20731 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, MAOA, MMP12, SRC, XDH |
2.20045 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.19319 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.1619 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.1619 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, FLT3, IGF1R, MAP2K1, MAP3K7, PTPN1, SRC |
2.12268 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APEX1, APP, AR, AXL, CYP1B1, IGF1R, RELA, RORC, SRC |
2.12268 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APEX1, APP, AXL, CYP1B1, RELA, SRC |
2.1036 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APEX1, APP, FABP3, FLT3, IGF1R, PPARA, RELA, SRC, TYR |
2.09455 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, APP, AR, CDC25B, FABP3, FLT3, KDR, MAP2K1, MAP3K7, PTPN1, SRC, XDH |
2.07846 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, APP, AR, CDC25B, FABP3, FLT3, KDR, MAP2K1, MAP3K7, PTPN1, SRC, XDH |
2.07846 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, APP, AR, AURKB, CDC25B, F3, FABP3, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP12, PPARA, PTPN1, RELA, RORC, SRC, TOP2A, XDH |
2.06392 |
[BP] GO:0048732 |
gland development
|
AR, CSNK2A1, CYP19A1, MAP2K1, RELA, TYR |
2.03775 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, APP, AR, AURKB, CDC25B, CSNK2A1, F3, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP12, PPARA, PTPN1, RELA, RORC, SRC, TOP2A, XDH |
2.03775 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, APP, AR, CDC25B, FLT3, KDR, MAP2K1, MAP3K7, PTPN1, SRC, XDH |
2.02299 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, APP, AR, CDC25B, FABP4, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, PPARA, PTPN1, SRC, XDH |
2.01987 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, GLO1, PIM1, PPARA, PTGES, TYR |
2.01987 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, FABP4, MAP3K7, MMP12, PPARA, PTPN1, PTPRS, RELA, SRC |
2.00231 |
[CC] GO:0005641 |
nuclear envelope lumen
|
ALOX5, APP, PTGES |
3.41839 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APEX1, APP, AR, AURKB, CA1, CA2, CA4, CA7, CACNA1C, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FDPS, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSD17B3, KDR, MAOA, MAP2K1, MAP3K7, MCL1, PIM1, PTGES, PTPN1, PTPRS, RELA, SRC, TOP2A, TYR, XDH |
2.8901 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ACHE, ADORA1, AKR1B1, AKR1B10, APEX1, APP, AR, AURKB, AXL, CA1, CA2, CA4, CA6, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, F3, FABP3, FABP4, FDPS, FLT3, FUT7, GLO1, HSD17B3, IGF1R, KDR, MAOA, MAP2K1, MAP3K7, MCL1, MMP12, PIM1, PPARA, PTPN1, PTPRS, RELA, RORC, SHBG, SRC, TOP2A, TYR, XDH |
2.69656 |
[CC] GO:0043226 |
organelle
|
ACHE, ADORA1, AKR1B1, AKR1B10, APEX1, APP, AR, AURKB, AXL, CA1, CA2, CA4, CA6, CACNA1C, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, F3, FABP3, FABP4, FDPS, FLT3, FUT7, GLO1, HSD17B3, IGF1R, KDR, MAOA, MAP2K1, MAP3K7, MCL1, MMP12, PIM1, PPARA, PTPN1, PTPRS, RELA, RORC, SHBG, SRC, TOP2A, TYR, XDH |
2.06564 |
[CC] GO:0005783 |
None
|
ADORA1, APEX1, APP, CA4, CYP19A1, FLT3, HSD17B3, KDR, MAP2K1, PTPN1, XDH |
2.03775 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7 |
9.7944 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, F3, FDPS, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSD17B3, IGF1R, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP12, PIM1, PTGES, PTPN1, PTPRS, SRC, TOP2A, TYR, XDH |
9.61605 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, APP, AR, CA1, CA12, CA2, CA4, CA6, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, GLO1, MMP12, PIM1, PPARA, PTPN1, RORC, TYR, XDH |
8.47236 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, APEX1, APP, AR, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, F3, FABP3, FABP4, FDPS, FLT3, GLO1, HSD17B1, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP12, PIM1, PPARA, PTGES, PTPN1, PTPRS, RELA, RORC, SRC, TOP2A, TYR, XDH |
8.47236 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA6, CA7 |
6.9823 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7 |
6.44818 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, APEX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD17B1, HSD17B2, HSD17B3, MAOA, TYR, XDH |
5.82107 |
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA6, CA7, GLO1 |
5.62299 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, CBR1, HSD17B1, HSD17B2, HSD17B3, XDH |
4.18269 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.65523 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, APEX1, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FDPS, GLO1, MAP3K7, MMP12, PIM1, PPARA, PTPN1, RORC, TOP2A, TYR, XDH |
3.52143 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MAP2K1, MET, SRC |
3.50565 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.50565 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, PPARA, SRC, TOP2A |
3.48663 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.48663 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, CBR1, HSD17B1, HSD17B2, HSD17B3 |
3.42836 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC |
3.23124 |
[MF] GO:0008270 |
zinc ion binding
|
AR, CA1, CA12, CA2, CA4, CA6, CA7, GLO1, MMP12, PPARA, PTPN1, RORC |
3.15127 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.10707 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, APEX1, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FDPS, GLO1, MAP3K7, MMP12, PIM1, PPARA, PTPN1, RORC, TOP2A, TYR, XDH |
3.09641 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, APEX1, CSNK2A1, FLT3, IGF1R, KDR, MMP12, PIM1, PPARA, PTPN1, RELA, SRC |
3.06419 |
[MF] GO:0042562 |
hormone binding
|
ACHE, AR, HSD17B1, IGF1R, SHBG |
2.97755 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, XDH |
2.84363 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, TYR |
2.78666 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
2.76297 |
[MF] GO:0043168 |
anion binding
|
APP, AURKB, AXL, CSNK2A1, F3, FABP3, FABP4, FLT3, HSD17B1, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, PTGES, PTPRS, RELA, SRC, TOP2A, XDH |
2.65263 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC |
2.62545 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, APEX1, FLT3, IGF1R, KDR, MMP12, PPARA, PTPN1, RELA, SRC |
2.5864 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC |
2.32055 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, SRC |
2.27441 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, SRC |
2.1619 |
[MF] GO:0005497 |
None
|
AR, SHBG |
2.1619 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD17B1, HSD17B2, HSD17B3 |
2.06629 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD17B1, PTGES, SRC, XDH |
2.03611 |